Canadian Cannabis Market: Page 2

Curaleaf Files Update to Offering Circular

The cannabis company has filed a formal update to its circular incorporating its previously announced increased offer for Aurora.

Aurora Maintains Shareholder Recommendation to Take No Action; Curaleaf Has Yet to File Revised Bid

Once Curaleaf files a Notice of Variation and Change to revise its offer, Aurora’s special committee will complete a comprehensive review.

Cannara Expands International Supply Agreement With Curaleaf

The amended agreement has a potential aggregate contract value of approximately C$34 million over its two-year term.

SNDL Board Director Abruptly Resigns

Carolo Cannell’s resignation is effective ‘immediately.’ The cannabis company provided no further details.

Rove Enters Canada With Ontario Launch

The leading U.S. cannabis vape brand marks first international expansion.

Aurora Cannabis Files Application With Alberta Securities Commission to Protect Company Shareholders

The company filed the application, having identified what it calls several deficiencies in Curaleaf’s hostile bid disclosure.

Canopy Growth Expands European Medical Cannabis Supply Into UK

The company will supply four Canadian-grown flower strains to distribute in the U.K. medical cannabis market under Spectrum Therapeutics.

Aurora Cannabis Provides Business Update

The company’s acquisition of Safari Flower and leading European performance are expected to fuel international growth in Q2 and beyond.

Curaleaf Sends Letter to Aurora Shareholders

Curaleaf Chairman and CEO Boris Jordan encourages Aurora’s shareholders to tender their shares and become owners of the world’s leading cannabis company.

Aurora Cannabis Refutes Curaleaf's Latest Attempt To Distract Shareholders From Facts

Aurora claims that Curaleaf’s latest announcement is a ‘desperate’ effort to shift shareholder attention away from a hostile bid that “undervalues’ Aurora.

Curaleaf Submits Application to Alberta Securities Commission to Halt Aurora's ATM Program During Pending Offer

The company argues Aurora’s share issuances are an improper and abusive defensive tactic that dilutes shareholders and interferes with the consideration of Curaleaf’s offer.

Canopy Growth Broadens Australian Medical Cannabis Portfolio With New Formats, Formulations

New pastille and all-in-one vape formats, expanded oil and softgel offerings, and new flower SKUs build on international growth momentum.

Previous Page

Page 2 of 21

Next Page